The groundbreaking approach of the medication represents a major development in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and https://tirzepatidepeptide257472.gynoblog.com/40773740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment